← Back to Analyst Consensus 
VRDN Buy
Viridian Therapeutics, Inc.\DE
Current Price —
Implied Upside —
Analysts 23
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 22, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jun 30, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jun 30, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jun 30, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Jun 30, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jun 29, 2026 | Wells Fargo | upgrade | Equal-Weight → Overweight | — | 54% |
| Jun 29, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| May 15, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| May 6, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 5, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Apr 21, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Apr 8, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Apr 7, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Apr 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Apr 2, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Mar 31, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Mar 31, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Mar 31, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Mar 31, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 30, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Mar 11, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Feb 27, 2026 | RBC Capital | maintain | Outperform → Outperform | $42 | 55% |
| Feb 4, 2026 | Needham | reiterate | Buy → Buy | $42 | 50% |
| Feb 3, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $29 | 54% |
| Jan 8, 2026 | Truist Securities | maintain | Buy → Buy | $40 | 54% |
| Jan 7, 2026 | UBS | initiate | — → Buy | $50 | 54% |
| Dec 23, 2025 | Needham | maintain | Buy → Buy | $42 | 50% |
| Dec 10, 2025 | Wedbush | maintain | Outperform → Outperform | $47 | 58% |
| Dec 3, 2025 | William Blair | initiate | — → Outperform | $0 | 48% |
| Nov 24, 2025 | Truist Securities | initiate | — → Buy | $41 | 54% |
| Nov 6, 2025 | RBC Capital | maintain | Outperform → Outperform | $45 | 55% |
| Nov 4, 2025 | BTIG | reiterate | Buy → Buy | $61 | 52% |
| Oct 21, 2025 | Oppenheimer | maintain | Outperform → Outperform | $36 | 52% |
| Aug 7, 2025 | Goldman Sachs | maintain | Buy → Buy | $30 | 54% |
| Aug 7, 2025 | RBC Capital | maintain | Outperform → Outperform | $41 | 55% |
| Aug 7, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $26 | 54% |
| Aug 7, 2025 | Oppenheimer | maintain | Outperform → Outperform | $32 | 52% |
| Aug 6, 2025 | Needham | maintain | Buy → Buy | $34 | 50% |
| May 20, 2025 | Needham | reiterate | Buy → Buy | $36 | 50% |
| May 7, 2025 | RBC Capital | maintain | Outperform → Outperform | $45 | 55% |
| May 7, 2025 | Goldman Sachs | maintain | Buy → Buy | $27 | 54% |
| May 7, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $38 | 53% |
| May 7, 2025 | Needham | maintain | Buy → Buy | $36 | 50% |
| Apr 23, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $34 | 44% |
| Jan 7, 2025 | Needham | reiterate | Buy → Buy | $38 | 50% |
| Dec 19, 2024 | Wells Fargo | downgrade | Overweight → Equal-Weight | $27 | 54% |
| Dec 17, 2024 | RBC Capital | maintain | Outperform → Outperform | $47 | 55% |
| Dec 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $34 | 44% |
Price Target Trend
Apr 17, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days